Brainstorm Cell Therapeutics Inc (STU:GHD)
€ 2.979 0 (0%) Market Cap: 9.73 Mil Enterprise Value: 7.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 36/100

Brainstorm Cell Therapeutics Inc Annual Shareholders Meeting Transcript

Dec 18, 2023 / 03:00PM GMT
Release Date Price: €2.88 (-6.80%)
Tony Carideo The Carideo Group;Inspector of Election

Hello, and welcome to the BrainStorm Cell Therapeutics Incorporated Annual Meeting of Stockholders. Please note that today's meeting is being recorded. (Event Instructions)

It is now my pleasure to turn today's meeting over to Chaim Lebovits, Chief Executive Officer of BrainStorm Cell Therapeutics Inc. Mr. Lebovits, the floor is yours.

Chaim Lebovits BrainStorm Cell Therapeutics Inc.;President
CEO

Thank you, Tony. Good morning. I am Chaim Lebovits, Chief Executive Officer of BrainStorm Cell Therapeutics Inc. Welcome to the BrainStorm December 2023 Annual Meeting.

For the avoidance of any doubt, today's meeting is the same as what was referenced as the 2024 Meeting of Stockholders in our proxy statement filed with SEC on December 13, 2022. With us today are Dr. Stacy Lindborg, Co-CEO; and Alla Patlis, Interim Chief Financial Officer.

We will be available following the formal part of the meeting to respond to questions from stockholders. Notice of this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot